KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Account Payables: 2014-2024

Historic Change in Account Payables for Palvella Therapeutics (PVLA) over the last 5 years, with Dec 2024 value amounting to $43,000.

  • Palvella Therapeutics' Change in Account Payables was N/A to $43,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $2.2 million for FY2024, which is 199.69% up from last year.
  • Palvella Therapeutics' Change in Account Payables amounted to $43,000 in Q4 2024, which was down 97.45% from $1.7 million recorded in Q3 2024.
  • Palvella Therapeutics' Change in Account Payables' 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of $43,000 in Q4 2024.
  • In the last 1 years, Palvella Therapeutics' Change in Account Payables had a median value of $255,000 in 2024 and averaged $559,500.